There was also significant difference between ductalcarcinoma in situ (or with early infiltration) and invasiveductalcarcinoma (P<0.05), and the former was weaker.
导管内癌(或伴早浸)与浸润性导管癌相比,表达水平低,差异有显著性意义(P<0.05)。
2
In this trial, women aged at least 45 years with invasiveductal breast carcinoma undergoing breast-conserving surgery were enrolled.